Valuation: Hofseth BioCare ASA

Market Cap 713M 74.4M 65.35M 60.77M 55.77M 105M 7.17B 106M 722M 282M 3.52B 279M 273M 12.18B P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 1.01B 105M 92.2M 85.74M 78.68M 148M 10.11B 150M 1.02B 398M 4.97B 394M 386M 17.18B EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
68.38%
Yield 2024 *
-
Yield 2025 -
1 day+0.74%
1 week-4.88%
Current month-1.09%
1 month+5.00%
3 months+5.41%
6 months+6.64%
Current year+3.41%
1 week 1.31
Extreme 1.31
1.5
1 month 1.23
Extreme 1.23
1.74
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.42
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
8.04
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 65 2009-12-31
Director TitleAgeSince
Director/Board Member 58 -
Director/Board Member 55 2015-04-30
Director/Board Member - 2021-12-02
Date Insider Type Main position Quantity % Market Cap.
7/14/23 Buy 74,000 0.0187%
2/28/23 Buy

Chief Technology Officer

200,000 0.0506%
2/17/23 Buy

Director

100,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%-4.88%-23.96%-55.68% 74.4M
+1.74%-5.70%+10.02%-23.35% 254B
+0.78%-0.79%-14.25%-17.85% 77.69B
+2.28%-4.08%+4.82%+25.22% 51.18B
-0.10%+0.18%+141.86%+503.13% 44.52B
-0.50%+0.02%+55.23%-1.13% 41.41B
+1.25%+1.68%-6.85%-27.51% 35.36B
+1.22%-0.81%-10.50%-29.40% 30.44B
-0.53%-3.50%+28.92%+81.52% 29.72B
+0.66%+0.38%+30.25%+30.16% 28.91B
Average +0.75%-1.52%+21.56%+48.51% 59.33B
Weighted average by Cap. +1.14%-2.86%+19.31%+29.92%

Financials

2024 2025
Net sales 266M 27.72M 24.34M 22.64M 20.77M 39.03M 2.67B 39.63M 269M 105M 1.31B 104M 102M 4.54B 256M 26.76M 23.5M 21.85M 20.05M 37.68M 2.58B 38.26M 260M 101M 1.27B 100M 98.28M 4.38B
Net income -125M -13.08M -11.49M -10.68M -9.8M -18.42M -1.26B -18.7M -127M -49.56M -619M -49.09M -48.04M -2.14B -135M -14.08M -12.36M -11.5M -10.55M -19.83M -1.36B -20.13M -137M -53.35M -667M -52.85M -51.71M -2.3B
Net Debt 145M 15.17M 13.32M 12.39M 11.37M 21.36M 1.46B 21.69M 147M 57.47M 718M 56.93M 55.71M 2.48B 293M 30.57M 26.85M 24.97M 22.91M 43.05M 2.94B 43.71M 297M 116M 1.45B 115M 112M 5B
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
26-07-24 NOK 1.365 +0.74% 98,875
26-07-23 NOK 1.355 -3.21% 43,793
26-07-22 NOK 1.400 +6.87% 24,341
26-07-21 NOK 1.310 -2.96% 36,486
26-07-20 NOK 1.350 -5.92% 108,720